NCT Number: NCT00493753
Feasibility and Safety of Acupuncture for Systemic Lupus
The aim of this pilot study was to evaluate whether acupuncture is safe and acceptable to people with systemic lupus erythematosus (SLE). Twenty-four SLE patients were assigned randomly to receive either 10 sessions of acupuncture, 10 sessions of a minimal-needling control intervention, or their usual medical care alone. It was hypothesized that acupuncture would be safe for people with SLE, and that participants would be able to complete their assigned treatment within 5 to 6 weeks.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
UPMC General Clinical Research Center, Pittsburgh, Pennsylvania, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- diagnosed with SLE, 18 years old or older, pain duration at least 3 times per week for at least 3 months, medications and doses stable for the past month, able to speak, read, and understand English, and provide informed consent.
Exclusion criteria
- known pregnancy, active uncontrolled organ involvement, steroid dose greater than 10 mg per day, platelets < 100,000, previous course of acupuncture treatment.
Treatment and study plan
Primary outcomes
-
Safety (side effect and adverse event rates), protocol adherence (expected 80% of sessions completed on time)
Time frame: 6 weeks
Secondary outcomes
-
pre-post treatment effect size estimates for self-reported pain and fatigue
Time frame: 6 weeks
Sponsors and collaborators
Lead sponsor
University of Pittsburgh
Other
Registry information
Official study title
Feasibility and Safety of Acupuncture for Systemic Lupus Erythematosus
Important dates
- Study start
- 2004
- Study completion
- 2006
- First posted
- Jun 28, 2007
- Registry last updated
- Jun 28, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions
NCT03938324
Anemia, Anemia, Hemolytic
Durham, North Carolina, United States
View Trial DetailsStudy of Families With Twins or Siblings Discordant for Rheumatic Disorders
NCT00055055
Arthritis, Arthritis, Rheumatoid
Bethesda, Maryland, United States
View Trial DetailsReducing Disparities in Medication Adherence in SLE
NCT03738826
Autoimmune Diseases, Behavior
Durham, North Carolina, United States
View Trial DetailsClinical and Demographic Features of Patients With Moderate to Severe Active Systemic Lupus Erythematosus in Russia
NCT06759519
Autoimmune Diseases, Connective Tissue Diseases
Barnaul, Russia
View Trial Details